Registry-listed formulations

retinol palmitate · mesh:C014794

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

3 source entries across 3 studies. This list may not include all unresolved or historical entries.

  • Vitamin A palmitateRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Vitamin A PalmitateRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • RETINOL PALMITATERegistry product

    Linked study entry; product equivalence not established

    Formulation reported by source: EYE OINTMENT

    View study and source

Success Metrics

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)

Phase Distribution

Phase 4
1
33%
Early Phase 1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (66.7%)
Phase 41 (33.3%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completedearly_phase_1

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

NCT03478878
completedearly_phase_1

Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation

NCT03478865
unknownphase_4

Treating discharge and discomfort of eye prosthesis: a comparison between vitamin A ointment, anti-inflammatory eye drops and standard eye drops

SYF0085a71e68074f20bb8d2f3ee4baa9c2

Clinical Trials (3)

Showing 3 of 3 trials
NCT03478878Early Phase 1

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

Completed
NCT03478865Early Phase 1

Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation

Completed
SYF0085a71e68074f20bb8d2f3ee4baa9c2Phase 4

Treating discharge and discomfort of eye prosthesis: a comparison between vitamin A ointment, anti-inflammatory eye drops and standard eye drops

Unknown

All 3 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
3

Names & Codes

Trade Names

Chocola A